宏力醫療管理:年報 2023
Honliv Healthcare Management Posts Lower 2023 Profit Despite Higher Revenue
Honliv Healthcare Management Group (HKG:9906) reported profit and total comprehensive income attributable to the owners of 38.3 million yuan for the year ended Dec. 31, 2023, compared with profit of 4
Hongli Healthcare Management (09906) announced annual results. Profit attributable to shareholders of 38.31 million yuan decreased 21.7% year over year
Hongli Healthcare Management (09906) announced the results for the year ended December 31, 2023, and the group obtained revenue...
HONLIV HEALTH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023 AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY
Hongli Healthcare Management (09906.HK) plans to hold a board meeting on March 28 to consider and approve the annual results
Glonghui, March 18, 丨 Hongli Healthcare Management (09906.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the Group's annual results and announcements for the year ended 31 December 2023, consider paying a final dividend (if any), and deal with other matters.
HONLIV HEALTH: INTERIM REPORT 2023
HONLIV HEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023 AND CHANGE IN USE OF PROCEEDS
Hongli Healthcare Management (09906.HK) will hold a board meeting on August 25 to approve interim results
On August 14, GLONGWI | Hongli Healthcare Management (09906.HK) announced that the company will hold a board meeting on August 25, 2023 to consider and approve the Group's interim results and announcements for the six months ended June 30, 2023, and consider the payment of interim dividends (if any).
HONLIV HEALTH: DATE OF BOARD MEETING
Hongli Healthcare Management (09906.HK) Adopts 2023 Restricted Share Unit Plan
Glonghui May 9 丨 Hongli Healthcare Management (09906.HK) announced that the board of directors adopted the plan on May 9, 2023. The Board intends to direct the trustee to purchase a certain number of existing shares at the market transaction price in the secondary market at the appropriate time as a reward for the plan. The program aims to recognize and motivate the contributions of employees of any acquired entity, reward them for retaining them, and attract the right employees for the development of any acquired entity.
Hongli Healthcare Management: Annual Report 2022
Hongli Medical Management (09906.HK) annual revenue of 728 million yuan increased 19.9% year-on-year
Glonghui, March 27, 丨 Hongli Healthcare Management (09906.HK) announced that for the year ending December 31, 2022, the company's revenue was 728 million yuan, an increase of 19.9% over the previous year; profit attributable to the company's owners was 48.95 million yuan, an increase of 33.7% over the previous year; and basic and diluted profit per share was 0.08 yuan.
Hongli Healthcare Management: For the year ended December 31, 2022 Annual Results Announcement
Hongli Healthcare Management (09906.HK) plans to hold a board meeting on March 27 to approve annual results
Glonghui, March 15, 丨 Hongli Healthcare Management (09906.HK) announced that the company will hold a board meeting on March 27, 2023 (Monday) to consider and adopt the Group's annual results and announcements for the year ended December 31, 2022, consider the payment of a final dividend (if any), and handle other matters.
Hongli Medical Management: interim report 2022
Hongli Medical Management (09906.HK) adopts 2022 restricted share unit plan
Gelonghui August 22nd, Hongli Medical Management (09906.HK) announcement, the board of directors considered and approved the 2022 restricted share unit plan on August 22nd. The purpose of the scheme is to recognize and motivate participants for their contributions and to award incentives to retain them and to attract suitable staff for the further development of the Group. The total number of existing shares to be purchased by the trustee under the scheme will not exceed 2% of the total issued share capital of the company as at the adoption date. The shares purchased in the share pool will be allocated from the resources of the company. The sum of the maximum number of shares involved in awarding awards to selected participants shall not exceed the
The medium-term net profit of Hongli Medical Management (09906.HK) was 32.173 million yuan, an increase of 62.3% over the same period last year.
Hongli Medical Management (09906.HK) announced that for the six months ended June 30, 2022, the company achieved an income of 375 million yuan, an increase of 30.8% over the same period last year. During the period, the company's owner's profit was 32.173 million yuan, an increase of 62.3% over the same period last year. Basic and diluted profit per share was 0.05yuan. The increase in income was mainly due to increased revenue from the sale of treatment and integrated medical services and drugs. The main reason is: (I) after the first phase building was put into use, new diagnostic equipment was added, which provided a more comprehensive and reliable basis for clinical diagnosis; (ii)
Hongli Medical Management: six months ended June 30, 2022 Interim results announcement
Hongli Medical Management (09906.HK) will hold a board meeting on August 22nd to approve interim results.
09906.HK announced that the company will hold a board meeting on 22 August 2022 to consider and approve the interim results and announcements of the company and its subsidiaries for the six months ended June 30, 2022, and to consider paying an interim dividend (if any).
Hongli Medical Management: annual report 2021
No Data